FTC’s sham petition loss to Shire tees up potential federal court troubles
Drugmaker Shire has defeated a Federal Trade Commission lawsuit claiming that it delayed generic versions of the gastrointestinal drug Vancocin, despite a federal judge ruling that the company’s past conduct could...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content